Archives of Medical Biotechnology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Editorial, Arch Med Biotechnol Vol: 3 Issue: 1

Recent Advances in Biotechnology and Reports

Rajesh Kumar*

Department of Biotechnology, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, India.

*Corresponding Author:

Rajesh Kumar
Department of Biotechnology, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, India.
E-mail:[email protected]

Received date: 04 January, 2022, Manuscript No. AMB-22-57084;
Editor assigned date: 10 January, 2022, PreQC No. AMB-22-57084(PQ);
Reviewed date: 19 January, 2022, QC No. AMB-22-57084;
Revised date: 28 January, Manuscript No. AMB-22-57084(R);
Published date: 04 February, 2022, DOI: 10.4172/amb.1000e001

Citation: Rajesh K (2022) Recent Advances in Biotechnology and Reports. Arch Med Biotechnol 03:01.

Keywords: Biotechnology

Introduction

Biotechnology is the use of organic standards to supply value-introduced merchandise and/or approaches. How this definition is very huge and that is due to the fact biotechnology software field is very extensive. In as much those biotechnology applications are nicknamed with different shades depending on its application: associated with industry, they are looking for to discover solutions to industrial methods. Answers that we're seeking out include: How to make ethanol from a plant. The way to produce a molecule from bio-primarily based raw materials. How to make customer merchandise higher. Businesses on this discipline include novozymes, dupont and BASF. Red biotechnology is related to medicine, they find solutions that improve the fitness care of sufferers. Solutions that we're searching out include: a way to treatment or treat a disorder. How to diagnose a disease. Organizations on this area include genentech, amgen and tehran. Green biotechnology is associated with agriculture; they are looking for to improve the yield and high-quality of agricultural tactics. Solutions that we are seeking out include: How to make a plant drought resistant. The way to enhance the yield of a plant. The way to produce an agent which can kill insects. Businesses in this area include Monsanto, DuPont and BASF. Grey biotechnology is related to environment, they are searching for to find ways to help the environment with biological procedures. Solutions that we're seeking out consist of: How to bio remediate a chemical spill. What sort of organisms may be discovered in the surroundings that are beneficial. Presently there are no massive businesses in this discipline. Blue biotechnology is related to oceans, they searching for to leverage oceans to create merchandise and techniques for industry. Answers that could be doubtlessly obtained are nevertheless relatively of their early degrees. Obviously, no massive companies exist in this area either [1].

CRISPR

Clustered Regularly Interspersed Quick Palindromic Repeats (CRISPR) is a quite new gene enhancing gadget that has been hailed as a ground-breaking tool in clinical research. Many makes use of, HIV studies is one among them. Researchers can now keep up with the consistent genetic mutations with the aid of actively trying out newly observed mutations and continuously modifying them to tweak focused cures [2]. Liquid biopsies discover signs of actual DNA, or cellular-free Circulating Tumour DNA (ctDNA), this is shed from a tumor into the bloodstream. This ctDNA is greater than 100 times extra considerable within the blood than tumour cells. While studies are nonetheless underway, annual sales of this innovative cancer check are forecast to be $10 billion. Several businesses are developing trying out kits to hit the market these 12 months. Specialists believe that it's far handiest a count number of time earlier than catching and treating cancer is as a habitual like the annual check-up.

Stem Mobile Research

Stem cells can hold dividing infinitely and have the potential to distinguish into different sorts body cells, at some stage in the early development of an organism. In a laboratory, researchers can software these stem cells to distinguish into specific form of cells. This is where the innovation of biotechnology steps in [3]. considers a character with degenerative spinal disease that critically affects their high-quality-of-life. With the assist of stem cellular studies, it is probably possible to grow those stem cells in vitro, in a lab placing, after which implanted lower back into the affected character's frame. This would assist restore their cognitive acuity, imaginative and prescient, hearing, and different bodily features. This may sound a long way-fetched and prefer a plot from a sci-fi film; however the initial outcomes were promising.

Blood Transfusions through Genome Sequencing

Scientists from Brigham and ladies's hospital, Harvard medical college, and big apple Blood middle have are running in the direction of integrating entire genome sequencing facts into medical remedy. They desire to develop a set of rules which can decide differences in people blood sorts with extra than 99% accuracy. The intention of this assignment is to modernize remedy with the aid of figuring out uncommon blood donors and at-chance recipients before blood transfusions [4].

Innovations in Biotechnology

The arena's first and simplest genetically modified bioluminescent orchid has been efficiently evolved. To create the bioluminescent orchid, tissues from orchids (the Dendrobium genus) using the firefly luciferase gene. Using a way called "particle bombardment", biologically lively DNA from the firefly gene turned into delivered into orchid tissues. Converted cells have been identified by way of their bioluminescence trait. Those converted tissues had been propagated and used to generate transgenic flora (vegetation with an overseas gene integrated). This manner becomes repeated numerous instances and the bioluminescent trait were found in all transgenic plants. This confirms that the firefly luciferase gene has been integrated into the orchid. Not like the fluorescent developments which store and re-emit mild strength, the bioluminescent trait of the orchid makes use of its own electricity to create light [5]. These bioluminescent orchids will produce consistent light, visible to the human eye, for up to five hours in a stretch. This greenish-white mild is emitted from the complete orchid, such as roots, stem, leaves and petals. The depth of light produced varies throughout the one-of-a-kind components, starting from 5000 to 30,000 photons consistent with 2d. Genetic transformation can help complement conventional breeding of orchids to create orchids with proper traits, including novel colorings, longer shelf life and improved resistance to pests and diseases. It's also viable that this method may be used for the transformation of different species [6-9].

Biological Computing

This approach to computing has drawbacks but also benefits. Chemical pathways tend to be slow compared to silicon computing, not producing results for minutes or hours. However, biological computers have the capacity to be massively parallel, which lends itself to certain categories of computing problems. Also, cells and enzymes have their own actuators; not only can they compute a result; they can then physically move things around based on that result. We eventually want molecular scale nabobs that can assemble things for us, monitor and maintain our health, but the hardware for these poses enormous engineering hurdles. Living cells provide premade hardware; we only need to give them the right software [10].

Reference

  1. De Rubertis F, Fleck R, Lanthaler W (2009) Six secrets to success how to build a sustainable biotech business. Nat Biotechnol 27: 595â??597.

    [Crossref] [Google Scholar]

  2. Lee DP, Dibner MD (2005) The rise of venture capital and biotechnology in the US and Europe. Nat Biotechnol 23: 672â??676.

    [Crossref] [Google Scholar] [Indexed]

  3. DiMasi JA, Grabowski HG (2007) The cost of biopharmaceutical R&D: Is biotech different. Manage Decis Econ 28: 469â??79.

    [Crossref] [Google Scholar]

  4. Nelson AL, Dhimolea E, Reichert JM (2010) Development trends for human monoclonal antibody therapeutics. Nat Rev Drug Discov 9: 767â??74.

    [Crossref] [Google Scholar] [Indexed]

  5. Ebbers HC, Crow SA, Vulto AG, Schellekens H (2012) Interchangeability, immunogenicity and biosimilars. Nat Biotechnol 30: 1186 â?? 90. 

    [Crossref] [Google Scholar] [Indexed]

  6. Markusson N (2020) The co-evolution of technological promises, modelling, policies and climate change targets. Nat Clim Chang 10: 392-397.

    [Crossref] [Google Scholar]

  7. MaÅ?yska A (2019) The microbiome: A life science opportunity for our society and our planet. Trends Biotechnol 37: 1269-1272.

    [Crossref] [Google Scholar] [Indexed]

  8. Whelan AI, Lema MA (2017) A research program for the socioeconomic impacts of gene editing regulation. GM Crops Food 8: 74â??83.

    [Crossref] [Google Scholar] [Indexed]

  9. Zhang R, Liu J, Chai Z, Chen S, Bai Y, et al. (2019) Generation of herbicide tolerance traits and a new selectable marker in wheat using base editing. Nat Plants 5: 480â??485. 

    [Crossref] [Google Scholar] [Indexed]

  10. Poppell CA, Hayes RM, Mueller TC (2002) Dissipation of nicosulfuron and rimsulfuron in surface soil. J Agric Food Chem 50: 4581â??4585 (2002).

    [Crossref] [Google Scholar] [Indexed]

Track Your Manuscript